The HIV/AIDS Medical Advisory Committee (MAC) serves DPBH-OHA in much the same capacity as any Pharmacy and Therapeutics Committee or Formulary Committee in its execution of reviewing new and existing medications. MAC will make recommendations for medications to be included on or deleted from the ADAP formulary based on research, safety and how well the medications work, on which HIV antiretroviral (ARV) medications are the most effective in treatment, selecting the most cost-effective medications in each therapeutic class, and the like. Please see the following links to access the Medical Advisory Committee Policy and Procedures and the Medical Advisory Committee Bylaws.
The HIV/AIDS Medical Advisory Committee (MAC) Meetings are held twice a year.
